p-(4-chlorobutyl)phenol | 21782-54-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 英文名称: p-(4-chlorobutyl)phenol
• 英文别名: 4-(p-Hydroxy-phenyl)-butylchlorid；4-(4-chlorobutyl)phenol；1-chloro-4-(4-hydroxyphenyl)butane
• CAS: 21782-54-7
• 化学式: C₁₀H₁₃ClO
• 分子量: 184.666
• InChiKey: GIIWXDWASNELTI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  12
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  p-(4-chlorobutyl)phenol 在 sodium hydroxide 作用下， 120.0~200.0 ℃ 、50.0 Pa 条件下， 以47%的产率得到螺[4.5]癸-6,9-二烯-8-酮
  参考文献：
  名称：

  Acid-labile ester monomer having spirocyclic structure, polymer, resist composition, and patterning process

  摘要：

  一种酸敏感酯单体，其为螺环结构，化学式为（1），其中Z为具有可聚合双键的一价基团，X为形成环戊烷、环己烷或去甲基环辛烷环的二价基团，R2为H或一价碳氢基团，R3和R4为H或一价碳氢基团，或者R3和R4结合在一起，代表形成环戊烷或环己烷环的二价基团，n为1或2。从酸敏感酯单体获得的聚合物在酸催化消除反应中具有很高的反应性，因此可以用于制备具有高分辨率的光刻胶组合物。

  公开号：

  US08791288B2
• 作为产物：
  描述：

  4-(4-羟基苯基)-1-丁醇 在 氯化亚砜 、 三乙胺 作用下， 以 二氯甲烷 为溶剂， 反应 1.5h， 生成 p-(4-chlorobutyl)phenol
  参考文献：
  名称：

  2-Phenoxy-indan-1-one derivatives as acetylcholinesterase inhibitors: A study on the importance of modifications at the side chain on the activity

  摘要：

  As a part of our project aimed at developing new agents of potential application in AD, a new series of 2-phenoxy-indan-1-one derivatives which possess alkylamine side chain were designed, synthesized and evaluated for their inhibitory activity against AChE and BuChE. Most of the compounds were found to inhibit AChE in the nanomolar range. The optimum inhibitor 3g exhibited 34-fold increase in AChE inhibition than donepezil and displayed neuroprotective effect against H2O2-induced cell death. (C) 2008 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2008.07.014

文献信息

• ACID-LABILE ESTER MONOMER HAVING SPIROCYCLIC STRUCTURE, POLYMER, RESIST COMPOSITION, AND PATTERNING PROCESS
  申请人：Kinsho Takeshi

  公开号：US20100304295A1

  公开（公告）日：2010-12-02

  An acid-labile ester monomer of spirocyclic structure has formula (1) wherein Z is a monovalent group having a polymerizable double bond, X is a divalent group which forms a cyclopentane, cyclohexane or norbornane ring, R 2 is H or monovalent hydrocarbon, R 3 and R 4 are H or monovalent hydrocarbon, or R 3 and R 4 , taken together, stand for a divalent group which forms a cyclopentane or cyclohexane ring, and n is 1 or 2. A polymer obtained from the acid-labile ester monomer has so high reactivity in acid-catalyzed elimination reaction that the polymer may be used to formulate a resist composition having high resolution.

  一种酸敏感酯单体具有螺环结构，其化学式如下（1），其中Z是具有可聚合双键的一价基团，X是形成环戊烷、环己烷或诺邦烷环的二价基团，R2是H或一价碳氢基团，R3和R4是H或一价碳氢基团，或者R3和R4一起表示形成环戊烷或环己烷环的二价基团，n为1或2。从酸敏感酯单体获得的聚合物在酸催化消除反应中具有很高的反应性，因此可以用于制备具有高分辨率的抗蚀组合物。
• Heterocyclic ketone and thioester compounds and uses
  申请人：GPI NIL Holdings, Inc.

  公开号：US20020193420A1

  公开（公告）日：2002-12-19

  This invention relates to neurotrophic, low molecular weight, small molecule heterocyclic ketone and thioester compounds, compositions containing the same, and the use of such compounds for treating neurological disorders, including physically damaged nerves and neurodegenerative diseases.

  本发明涉及神经营养因子、低分子量、小分子杂环酮和硫酯化合物，含有这些化合物的组合物以及使用这些化合物治疗神经系统疾病，包括受到物理损伤的神经和神经退行性疾病。
• Heterocyclic compounds, oxazole derivatives, process for preparation of the same and use thereof
  申请人：——

  公开号：US20040242659A1

  公开（公告）日：2004-12-02

  This invention provides a heterocyclic compound having potent tyrosine kinase-inhibiting activity represented by the formula: 1 wherein m is an integer of 1 to 3; n is an integer of 1 or 2; R 1 is a halogen atom or an optionally halogenated C 1-2 alkyl group; each of R 2 and R 3 is, same or different, a hydrogen atom, a halogen atom, a lower alkyl group or a lower alkoxy group; R 4 is a group represented by the formula: 2 wherein p is an integer of 2 to 5; R 5 is a C 1-4 alkyl group substituted by alkoxycarbonyl group, carbamoyl group, carbamoyloxy group, alkylsulfonyl group, alkylsulfinyl group, sulfamoyl group, carbamoylamino group, alkylsulfonylamino group, acylamino group, and the like; or a salt thereof and a pharmaceutical composition comprising thereof.

  本发明提供了一种具有强大的酪氨酸激酶抑制活性的杂环化合物，其表示为公式1：其中，m为1至3的整数；n为1或2的整数；R1为卤素原子或可选卤代的C1-2烷基；R2和R3中的每一个，相同或不同，为氢原子、卤素原子、低烷基或低烷氧基；R4为公式2所表示的基团：其中p为2至5的整数；R5为被取代的C1-4烷基，取代基为烷氧羰基基团、氨基甲酰基团、氨基甲氧基基团、烷基磺酰基团、烷基亚磺酰基团、磺酰胺基团、氨基甲酰氨基团、烷基磺酰氨基团、酰胺基等；或其盐和含有其的制药组合物。
• Intramolecular Partners in Asymmetric Catalysis Copolymerization: Highly Enantioselective and Controllable at Enhanced Temperatures and Low Loadings
  作者：Yi‐Ning Li、Ye Liu、Han‐Han Yang、Wen‐Fu Zhang、Xiao‐Bing Lu

  DOI：10.1002/anie.202202585

  日期：2022.5.23

  Excellent enantioselectivity, activity and no transesterification side reactions were achieved in the asymmetric copolymerization of meso-epoxides and anhydrides at low catalyst loadings or/and enhanced temperatures via intramolecularly bimetallic and multichiral synergistic catalysis.

  通过分子内双金属和多手性协同催化，在低催化剂负载量或/和提高温度下内消旋环氧化物和酸酐的不对称共聚中实现了优异的对映选择性、活性和无酯交换副反应。
• HETEROCYCLIC COMPOUNDS, OXAZOLE DERIVATIVES, PROCESS FOR PREPARATION OF THE SAME AND USE THEREOF
  申请人：Takeda Chemical Industries, Ltd.

  公开号：EP1439178A1

  公开（公告）日：2004-07-21

  This invention provides a heterocyclic compound having potent tyrosine kinase-inhibiting activity represented by the formula: wherein m is an integer of 1 to 3; n is an integer of 1 or 2; R1 is a halogen atom or an optionally halogenated C1-2 alkyl group; each of R2 and R3 is, same or different, a hydrogen atom, a halogen atom, a lower alkyl group or a lower alkoxy group; R4 is a group represented by the formula: wherein p is an integer of 2 to 5; R5 is a C1-4 alkyl group substituted by alkoxycarbonyl group, carbamoyl group, carbamoyloxy group, alkylsulfonyl group, alkylsulfinyl group, sulfamoyl group, carbamoylamino group, alkylsulfonylamino group, acylamino group, and the like; or a salt thereof and a pharmaceutical composition comprising thereof.

  本发明提供了一种具有强效酪氨酸激酶抑制活性的杂环化合物，由式表示： 其中m是1至3的整数；n是1或2的整数；R1是卤素原子或任选卤化的C1-2烷基；R2和R3中的每一个相同或不同，是氢原子、卤素原子、低级烷基或低级烷氧基；R4是由式表示的基团： 其中 p 是 2 至 5 的整数；R5 是被烷氧羰基、氨基甲酰基、氨基甲酰氧基、烷基磺酰基、烷基亚磺酰基、氨基磺酰基、氨基甲酰基氨基、烷基磺酰基氨基、酰氨基等取代的 C1-4 烷基；或其盐和包含其的药物组合物。